Zanutigh V, Galetto L, Valvecchia F, Logioco C.
Ocular Surface Evaluation after Switch from Latanoprost 0.005% to Latanoprostene Bunod 0.024%. 
J Curr Glaucoma Pract
2023;
17
(4):205-209.